BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced a strategic collaboration with AstraZeneca, a global, science-led biopharmaceutical company ...

Dark Blue Therapeutics ("Dark Blue"), a discovery and development biotech company pioneering the next generation of precision oncology medicines, has been acquired by Amgen . Dark Blue's lead ...

Looking for the best AI chat app? I have culminated a list of the best AI tools, that I have tested and ranked in this read.

Read our live updates from CES 2026 in Las Vegas to see the latest consumer gadgetry in all of its chatbot-enabled, ...

Biju Dharmapalan [email protected] India’s journey toward becoming a self-sufficient and self-reliant nation has been ...

Wilmington, Del.-based Nemours Children's shared plans in early December to open an institute for maternal-fetal health aimed at improving care ...

MarketsandMarkets forecasts the sector will expand at 38.6% annually through 2030 [3], driven by chronic disease burden and data explosion. The FDA cleared over 1,250 AI-enabled medical devices by mid ...

Katie Colling is using tiny tumor models to find uterine cancer interventions that don’t require surgery Katie Colling didn’t ...

Write the name of a place (house, spot in nature, work, restaurant, etc.) at the top of your paper, and then do a stream-of-consciousness writing about that place and see what bubbles up. Pick a ...

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

Dr Emma Svennberg, cardiologist in Stockholm and first author of the consensus paper, noted that modern AF care requires a more streamlined and holistic approach. She highlighted the need to address ...

Virtual cells can teach us cellular biology. Virtual patients will teach us why therapies succeed or fail. Precision medicine ...